Dyslipidemia, or abnormal lipid levels, is common in CKD patients. Elevated levels of low-density lipoprotein (LDL) and decreased levels of high-density lipoprotein (HDL) contribute to the formation of atherosclerotic plaques, which can lead to coronary artery disease and other cardiovascular events. Managing lipid levels is crucial in reducing cardiovascular risk in renal patients.
